| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4fd06d1fa69c6d6fb68196b18f7048a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate |
2020-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbddd9df5d837d68afaa74850f3d0b08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29452213c3d11670f4354f41894a00e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f252cfb6061ee66d34d8fcabfd8fd837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67e2b809b1a8988d208156037a987ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_687dad095afa8cf67e74a92e030bff5b |
| publicationDate |
2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2749940-C1 |
| titleOfInvention |
Method for treatment of aneurysm of distal anastomosis of synthetic aorto-femoral shunt |
| abstract |
FIELD: medicine; vascular surgery.SUBSTANCE: formation of bifurcation of the common femoral artery of the patient with a cadaveric allograft is performed. The cadaveric allograft is pre-conditioned in a solution for the cultivation of Roswell Park Memorial Institute 1640 cell structures with the addition of 400 mcg/ml of gentamicin and 20 mcg/ml of fluconazole at a temperature of +4°C for a maximum of 4 weeks.EFFECT: method allows avoiding suppuration, achieving primary wound healing, and preventing fatal arrosive bleeding.1 cl, 1 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2789746-C1 |
| priorityDate |
2020-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |